FDA’s New Policy and Risk-Based Strategic Regulatory Updates for Critical Consideration
Conference Dates:
Start Date: 2018-05-22Last Day: 2018-05-22
Deadline for abstracts/proposals: 2018-05-21
Conference Contact Info:
Contact Person: AlanEmail: [email protected]
Address: Online Event, Online Event, Canada
Tel: 416-915-4438/ 58
Conference Description:
In FDA-regulated industries, it is imperative that firms should be well aware of and understand the laws and regulations governing FDA-regulated medical products (e.g., food, drugs, biologics, cosmetics, and medical devices including in vitro diagnostics). In particular, it is important to recognize policy changes and risk-based, strategic regulatory and compliance approaches (best practices) under the new administration.Areas Covered in the Session :
>. Laws and regulations
>. New administration
>. FDA policy
>. FDA enforcement
>. Risk-based approaches
>. Industry misconceptions
>. FDA inspection preparation and management
Who Should Attend:
>. CEOs
>. VPs
>. Compliance officers
>. Attorneys
>. Regulatory Affairs Departments
>. Clinical Affairs Departments
>. Quality Assurance Departments
>. R&D Departments
>. Consultants
>. Contractors/Subcontractors